Cargando…
Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1
VEGF and VEGFR antibodies have been used as a therapeutic strategy to inhibit angiogenesis in many diseases; however, frequent and repeated administration of these antibodies to patients induces immunogenicity. In previous studies, we demonstrated that aggretin, a heterodimeric snake venom C-type le...
Autores principales: | Chung, Ching Hu, Chang, Chien Hsin, Hsu, Chun Chieh, Lin, Kung Tin, Peng, Hui Chin, Huang, Tur Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333632/ https://www.ncbi.nlm.nih.gov/pubmed/28252668 http://dx.doi.org/10.1038/srep43612 |
Ejemplares similares
-
Snake Venom Disintegrin Inhibits the Activation of Toll-Like Receptors and Alleviates Sepsis through Integrin alphaVbeta3 Blockade
por: Hsu, Chun-Chieh, et al.
Publicado: (2016) -
Anti-thrombotic agents derived from snake venom proteins
por: Huang, Tur-Fu, et al.
Publicado: (2016) -
From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent
por: Kuo, Yu-Ju, et al.
Publicado: (2019) -
Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway
por: Chen, Jui-Chieh, et al.
Publicado: (2015) -
Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit
Publicado: (1995)